Not a cream, collagen matrix. It's a wound dressing, quite a few already out there. Assuming this goes as planned, Avita will pay $2M end of this year, $3M a year later. Also in for R&D expenses, undisclosed. No price point discussed. Another expensive distribution deal with products in already crowded markets with possible payback off in the future. Our European partner became Recell's distributor for next to nothing. Maybe JC needs to get some lessons from that guy. And before you correct me Salty, JC himself described the Permeaderm market as crowded near the end of the Q call or the webinar, don't remember which. Went back and listened for a 3rd time.
AVH Price at posting:
$3.02 Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)